|
Market Closed -
Nasdaq Helsinki
02:00:00 25/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 79.10 EUR | -0.19% |
|
+2.20% | +24.27% |
| 10/08 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
| 10/08 | Orion partner's phase 3 study with levosimendan missed its goals | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq Helsinki
ORNBV 79.10 €
-0.19%
6.03M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Helsinki
| ORNBV | 79.10EUR | -0.19% | 6.03M € | |
CBOE
| ORNBVh | 79.08EUR | +0.03% | 3.31M € | |
|
Boerse Muenchen
| OFK | 79.20EUR | +0.13% | 1.11K € | |
|
Tradegate
| OFK | 79.10EUR | -0.19% | 711.9 € | |
|
London S.E.
| 0M2O | 78.92EUR | +0.10% | 157.85 € | |
|
Deutsche Boerse AG
| OFK | 78.90EUR | -0.13% | 0 € | |
|
CBOE
| 0M2O | 78.80EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| OFK | 79.00EUR | -0.19% | 0 € | |
|
Berne S.E.
| OFK | 74.03CHF | +0.06% | 0 CHF | |
|
Borsa Italiana
| 1ORNBV | 76.35EUR | -3.11% | 0 € | |
Nasdaq Helsinki
| ORNAV | 79.00EUR | 0.00% | 202K € | |
|
CBOE
| ORNAVh | 78.80EUR | -0.13% | 83.29K € | |
|
CBOE
| 0M2N | 63.25EUR | 0.00% | 0 € | |
|
Deutsche Boerse AG
| OFKB | 78.00EUR | 0.00% | 0 € | |
Deutsche Boerse AG
| OFK0 | 39.40EUR | +1.55% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 82.25 | 82.25 | 81.5 |
| Spread/Res. | -3.83% | -3.83% | -2.94% |
| Spread/Supp. | +5.19% | +9.63% | +17.45% |
| Support | 75.2 | 72.15 | 67.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
Select your edition
All financial news and data tailored to specific country editions
